XML 25 R15.htm IDEA: XBRL DOCUMENT v3.24.0.1
Earnings Per Share
 12 Months Ended
Dec. 31, 2023
Earnings Per Share [Abstract]  
Earnings Per Share

4. Earnings Per Share

The following table sets forth the computation of basic and diluted (loss) earnings per share for the years ended December 31, 2023, 2022 and 2021 (in thousands, except per share amounts):

 

 

 

Year Ended December 31,

 

 

 

2023

 

 

2022

 

 

2021

 

Numerator:

 

 

 

 

 

 

 

 

 

(Loss) income from continuing operations attributable to Acadia
    Healthcare Company, Inc.

 

$

(21,667

)

 

$

273,139

 

 

$

203,276

 

Loss from discontinued operations

 

 

—

 

 

 

—

 

 

 

(12,641

)

Net (loss) income attributable to Acadia Healthcare
    Company, Inc.

 

$

(21,667

)

 

$

273,139

 

 

$

190,635

 

Denominator:

 

 

 

 

 

 

 

 

 

Weighted average shares outstanding for basic
   earnings per share

 

 

90,949

 

 

 

89,680

 

 

 

88,769

 

Effects of dilutive instruments

 

 

—

 

 

 

1,875

 

 

 

2,024

 

Shares used in computing diluted earnings per
   common share

 

 

90,949

 

 

 

91,555

 

 

 

90,793

 

 

 

 

 

 

 

 

 

 

 

Basic (loss) earnings per share attributable to Acadia
   Healthcare Company, Inc. stockholders:

 

 

 

 

 

 

 

 

 

(Loss) income from continuing operations attributable to
     Acadia Healthcare Company, Inc.

 

$

(0.24

)

 

$

3.05

 

 

$

2.29

 

Loss from discontinued operations

 

 

—

 

 

 

—

 

 

 

(0.14

)

Net (loss) income attributable to Acadia Healthcare
    Company, Inc.

 

$

(0.24

)

 

$

3.05

 

 

$

2.15

 

 

 

 

 

 

 

 

 

 

 

Diluted (loss) earnings per share attributable to Acadia
   Healthcare Company, Inc. stockholders:

 

 

 

 

 

 

 

 

 

(Loss) income from continuing operations attributable to
     Acadia Healthcare Company, Inc.

 

$

(0.24

)

 

$

2.98

 

 

$

2.24

 

Loss from discontinued operations

 

 

—

 

 

 

—

 

 

 

(0.14

)

Net (loss) income attributable to Acadia Healthcare
    Company, Inc.

 

$

(0.24

)

 

$

2.98

 

 

$

2.10

 

For the year ended December 31, 2023, approximately 0.9 million outstanding shares of restricted stock and shares of common stock issuable upon exercise of outstanding stock option awards have been excluded in the calculation of weighted-average shares outstanding-diluted. These shares are excluded from the calculation of diluted earnings per share in the condensed consolidated statement of operations because the net loss for the year ended December 31, 2023 causes such securities to be anti-dilutive. Approximately 0.3 million, 0.1 million and 0.3 million shares of common stock issuable upon exercise of outstanding stock options were excluded from the calculation of diluted earnings per share for the years ended December 31, 2023, 2022 and 2021, respectively, because their effect would have been anti-dilutive.